حدد سهمًا أو عملة مشفرة في شريط البحث للحصول على ملخص
Jacobson Pharma Corporation Ltd
2633Jacobson Pharma Corporation Limited, through its subsidiaries, develops, produces, markets, and sells generic drugs and branded healthcare products in Hong Kong, Mainland China, Macau, Singapore, and internationally. The company offers generic drugs for various therapeutic categories, including gastrointestinal disorders, cardiovascular conditions, inflammatory and autoimmune diseases, multiple myeloma treatment, oncology, breast cancer therapy, central nervous system, respiratory, oral antidiabetics, musculo-skeletal, genito-urinary, anti-infectives, endocrine and metabolic, dermatological, and anti-allergics. It also provides branded medicines; health and wellness products; and proprietary Chinese medicines; treasury services; and management services. In addition, the company engages in the manufacture, sale, trading of pharmaceutical products; property holding activities; holding of pharmaceutical licenses; trading of medical supplies; sales of healthcare and herbal products; and procurement of packaging materials. It sells its products to hospitals and clinics, and registered pharmacies, as well as to private doctors and retail outlets, and trading companies. Jacobson Pharma Corporation Limited was incorporated in 2016 and is headquartered in Kwun Tong, Hong Kong. Address: Tower 1, Millennium City 1, Kwun Tong, Hong Kong
Analytics
سعر الهدف في وول ستريت
16.64 HKDنسبة السعر إلى الأرباح
5.9091العائد الربحي
7.3 %السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
السنة الحالية
العام الماضي
الربع الحالي
الربع الأخير
الشخصيات الرئيسية 2633
تحليلات الأرباح 2633
نمو الأرباح على مدى 5 سنوات
-7 %النمو المستمر
1 سنةمعدل الدفع 5 سنوات في المتوسط
25 %تاريخ الأرباح 2633
تقييم الأسهم 2633
المالية 2633
نتائج | 2019 | ديناميات |